3

OWNERSHIP DOCUMENT

Company: Acurx Pharmaceuticals, Inc.
Filed: June 24, 2021
Period of Report: June 24, 2021
Accession Number: 0001104659-21-085271

View Document ↗ View on SEC.gov ↗